NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)
ID: 355096Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355096

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-213.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00), aimed at supporting emerging independent investigators in dementia research. This grant facilitates the transition from mentored postdoctoral positions to independent faculty roles, providing funding in two phases: a mentored phase (K99) for up to two years and an independent phase (R00) for up to three years, specifically for research that does not involve leading independent clinical trials. The initiative emphasizes the importance of enhancing the scientific workforce to address dementia-related challenges and is particularly focused on promoting diversity among applicants. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for July 12, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-213-Full-Announcement.html
    PAR-24-213.html
    The Department of Health and Human Services announces the NINDS Alzheimer’s Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00) aimed at supporting rising independent investigators in dementia research. This funding opportunity facilitates the transition from mentored postdoctoral positions to independent faculty roles, offering two phases of funding: a mentored phase (K99) for up to two years and an independent phase (R00) for up to three years. Candidates, holding no more than four years of postdoctoral experience, must propose research that does not lead independent clinical trials, while still engaging with clinical trial experiences under mentorship. The initiative emphasizes biomedical research in ADRD, covering various research areas like basic biological mechanisms, disease comparisons, and clinical diagnostics. The awards depend on NIH appropriations, with a specified salary support structure and research costs, conditional on progress during the K99 phase and securing an independent position for R00 eligibility. The application process mandates compliance with extensive instructions, eligibility criteria, and a focus on career development for underrepresented groups in research. The initiative reflects NIH's goal to enhance the scientific workforce addressing dementia-related challenges.
    Similar Opportunities
    NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00) to promote diversity among independent researchers in the ADRD field. This grant aims to support exceptional postdoctoral candidates, particularly those from underrepresented backgrounds, in transitioning to tenure-track faculty positions, with a focus on research that does not involve leading independent clinical trials. The program consists of two phases: the mentored K99 phase, providing up to 2 years of support with a budget of up to $75,000 for salary, and the independent R00 phase, offering up to 3 years of funding with a maximum of $249,000, contingent upon securing an independent position. Interested applicants can find more information and apply before the closing date of July 12, 2027, by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-212.html.
    NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Advanced Postdoctoral Career Transition Awards to promote diversity in translational research related to Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity aims to support early-career investigators from underrepresented backgrounds, providing them with the necessary training and mentorship to develop critical research skills and transition into independent research roles. The program consists of two phases: the K99 phase for mentored training lasting up to two years, followed by the R00 phase, which offers independent research support for up to three years. Eligible applicants include various institutions and organizations, with a focus on enhancing the diversity of the research workforce. Interested parties should note that the application deadline is July 12, 2027, and can find more information at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the BRAIN Initiative Advanced Postdoctoral Career Transition Award (K99/R00) to promote diversity within the neuroscience workforce. This grant aims to support outstanding postdoctoral researchers from underrepresented backgrounds in transitioning from mentored positions to independent faculty roles, providing up to two years of mentored training followed by up to three years of independent research support. The initiative, which has an annual funding pool of approximately $4 million and aims to fund around 20 awards each year, emphasizes the importance of a diverse research community in advancing innovative solutions in brain health and neuroscience. Interested applicants can find more information and apply by March 13, 2026, and should direct inquiries to grantsinfo@nih.gov.
    BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the BRAIN Initiative Advanced Postdoctoral Career Transition Award (K99/R00) to promote diversity within the neuroscience workforce. This grant aims to support outstanding postdoctoral researchers with clinical or research doctorate degrees as they transition from mentored positions to independent faculty roles, thereby enhancing the representation of underrepresented backgrounds in NIH-supported research areas related to the BRAIN Initiative. The program is particularly focused on experimental studies involving human participants and emphasizes a commitment to supporting diverse candidates, including women and individuals from underrepresented racial and ethnic groups. NIH plans to allocate $4 million annually from 2024 to 2026, with an expectation to fund approximately 20 awards each year. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by March 13, 2026.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Career Transition Award (K22) specifically for intramural clinician-scientists within the National Institute of Neurological Disorders and Stroke (NINDS). This grant aims to support the transition of newly trained neurologist and neurosurgeon scientists into independent academic faculty positions, allowing them to engage in independently funded research alongside clinical activities, while explicitly excluding the leadership of clinical trials. The award provides funding over a five-year period, consisting of two years in an intramural fellowship followed by three years in an extramural role, with eligibility criteria requiring applicants to be within four years of completing their residency and to hold a clinical doctorate. Interested applicants can find more information and application details at the NIH Grants website, with the application deadline set for November 12, 2027, and inquiries directed to grantsinfo@nih.gov.
    NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIA Career Transition Award (K22), a federal grant aimed at facilitating the transition of mentored postdoctoral researchers to tenure-track faculty positions while advancing the mission of the National Institute on Aging (NIA). This three-year grant provides salary and research support for candidates who secure a faculty position within 12 months of award approval, emphasizing the importance of a robust career development plan aligned with NIA's research priorities. The program underscores the government's commitment to fostering a diverse scientific workforce in health research, with eligibility extending to various institutions, including historically black colleges and universities and tribal colleges. Interested applicants must submit their proposals by November 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has announced the "Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)." This program aims to support innovative research projects focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), specifically targeting early-stage and diverse researchers who have not previously received significant NIH funding in this field. The initiative is designed to generate pilot data that can lead to larger funding applications, thereby enhancing research capabilities and workforce diversity in biomedical research. Grants of up to $100,000 per year for two years are available, with the application process opening on January 16, 2025, and the closing date set for March 16, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Aging (NIA), is offering a Small Research Grant Program (R03) aimed at fostering the next generation of researchers in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This program supports innovative projects that enhance understanding, diagnosis, treatment, and care strategies for AD/ADRD, while also promoting workforce diversity and addressing health disparities in this field. Grants of up to $100,000 for a duration of two years are available, with a total of 12 awards expected for fiscal year 2024, amounting to $1.8 million in funding. Interested applicants must be affiliated with eligible organizations and are encouraged to submit their applications by March 16, 2026, with inquiries directed to grantsinfo@nih.gov for further information.